Stay updated on Letetresgene Autoleucel+Pembrolizumab in NY-ESO-1+ MM Clinical Trial

Sign up to get notified when there's something new on the Letetresgene Autoleucel+Pembrolizumab in NY-ESO-1+ MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Letetresgene Autoleucel+Pembrolizumab in NY-ESO-1+ MM Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.2 to v3.6.3 on the page, signaling a new version of the site's content or template. This is an internal update and does not alter the study details or user-visible information.
    Difference
    0.0%
    Check dated 2026-07-04T04:27:57.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.0 to v3.6.2, signaling a new site/documentation release. This reflects backend/versioning updates rather than changes to study details or user-facing features.
    Difference
    0.0%
    Check dated 2026-06-27T02:48:22.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    Enrollment is closed as indicated by the new status. The page adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment labeling and revision version to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-12T14:50:41.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page now shows the updated revision indicator v3.5.5, replacing the previous v3.5.4, indicating a new build of the page.
    Difference
    0.0%
    Check dated 2026-06-05T09:58:26.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.4, replacing the prior v3.5.3 tag. This indicates a minor page version update rather than any change to the study data.
    Difference
    0.0%
    Check dated 2026-05-14T23:09:09.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page shows a new revision label. It updates from Revision: v3.5.2 to Revision: v3.5.3, signaling a software release rather than substantive changes to the study data or content.
    Difference
    0.0%
    Check dated 2026-04-30T14:26:40.000Z thumbnail image

Stay in the know with updates to Letetresgene Autoleucel+Pembrolizumab in NY-ESO-1+ MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Letetresgene Autoleucel+Pembrolizumab in NY-ESO-1+ MM Clinical Trial page.